The Influence Of Knowledge Of Pulmonary Tuberculosis Patients On Compliance With Taking Anti-Tuberculosis Drugs

Siti Kemala Sari, Irma Yanti Rangkuti, Rizkia Annisa Umri, Kesuma Wardani


Abstract


Pulmonary tuberculosis (TB) is the second infectious disease in the world after Covid-19 and the thirteenth leading cause of death worldwide in 2021. Indonesia has the second highest number of TB patients in the world after India. TB can be cured with regular treatment for 6 months. Prolonged treatment can cause TB patients to become bored and lead to drug withdrawal, causing drug resistance problems. The better the patient's knowledge about TB disease, length of treatment, side effects and complications can influence the decision to encourage patients to adhere to their treatment. The success of Tuberculosis treatment is influenced by patient compliance in taking medication. The type of research used was observational analytic with a cross sectional approach to determine the relationship between knowledge and adherence to taking medication. . Respondents of this study were pulmonary TB patients at Tanjung Rejo Percut health center as many as 51 people. This study used a questionnaire in its implementation. The analysis test used is the gamma test. The results of the study showed a relationship between knowledge and compliance with taking antituberculosis drugs in pulmonary tuberculosis patients. (p value 0.023). The results of the study showed that the majority of male gender, productive age, the final category of treatment was complete (92.2%), namely cured (53.0%), not cured (39.2%) and incomplete (7.8%). The majority of patients' knowledge was 78.4% in the good category and the majority of TB patients' medication compliance was 64.7% in the high compliance category

Keywords


Adherence to medication, Knowledge, Tuberculosis

Full Text:

PDF

References


Amran, R., Abdulkadir, W., & Madania, M. (2021). Tingkat Kepatuhan Penggunaan Obat Anti Tuberkulosis Pada Pasien Di Puskesmas Tombulilato Kabupaten Bone Bolango. Indonesian Journal of Pharmaceutical Education, 1(1), 57–66.

Asmawanti, I., Mardiyaningsih, A., & Trilestari. (2022). Tingkat Kepatuhan Penggunaan Obat Antituberkulosis pada Pasien Poli Paru di RSU Muhammadiyah Ponorogo. Jurnal Ilmu Kesehatan Bhakti Setya Medika, 7(2), 38–46.

Kemenkes. (2021). Laporan Program Penanggulangan Tuberkulosis 2021. kementrian Kesehatan RI.

Kemenkes RI. (2020). PEDOMAN NASIONAL PELAYANAN KEDOKTERAN TATA LAKSANA TUBERKULOSIS (Issue Januari). Kemenkes RI. file:///C:/Users/hp/Downloads/UMUM_PNPK_revisi-1.pdf

Nurbaety, B., Wahid, A. R., & Suryaningsih, E. (2020). Gambaran Tingkat Pengetahuan dan Kepatuhan Pada Pasien Tuberkulosis di Rumah Sakit Umum Provinsi NTB Periode Juli-Agustus 2019. Lumbung Farmasi: Jurnal Ilmu Kefarmasian, 1(1), 8.

P2PL KEMENKES. (2020). PETUNJUK TEKNIS PENATALAKSANAAN TUBERKULOSIS RESISTAN OBAT DI INDONESIA Direktorat. Kemenkes RI.

Parlaungan, J., Huriani, Y., Mobalen, O., & Situmorang, P. (2021). FAKTOR YANG MEMPENGARUHI PENDERITA TB PARU DROP OUT MINUM OBAT ANTI TUBERKULOSIS. Nursing Arts, 15(1), 36–46.

Rani, R. S., Priyatno, A. D., & Harokan, A. (2022). Analisis kepatuhan minum obat TB paru pada masa pandemi di puskesmas Sukarami kota Palembang tahun 2022. Jurnal Kesehatan Saelmakers PERDANA, 6(1), 179–189.

Siburian, C. H., Damerius Silitonga, S., Nugraha, E., & Naibaho. (2023). Hubungan Pengetahuan dengan Kepatuhan Minum Obat pada Pasien Tuberkulosis Paru. Jurnal Kesehatan Masyarakat, 2(1), 160–168.

Singano, V., Kip, E., Ching’ani, W., & Chiwaula, L. (2020). Tuberculosis treatment outcomes among prisoners and general population in Zomba, Malawi. BMC Public Health, 20(1), 700.

WHO. (2022). GLOBAL TUBERCULOSIS REPORT (Issue 1). WHO.

Ziliwu, J. B. P., & Girsang, E. (2022). KEPATUHAN MINUM OBAT PADA PASIEN TUBERKULOSIS DI RS . KHUSUS PARU MEDAN THE RELATIONSHIP OF KNOWLEDGE AND ATTITUDES TOWARDS MEDICATION ADHERENCE IN TUBERCULOSIS PATIENTS IN MEDAN. Jambura Journal of Health Sciences and Research, 4(3), 999–1006




DOI: https://doi.org/10.30743/best.v6i2.8148

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.